cp wire

CP Wire Articles

FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease
  • The FDA previously granted ruxolitinib Breakthrough Therapy Designation for the treatment of acute GVHD
  • Jakafi is marketed by Incyte in the United States and by Novartis as Jakavi (... read more
Thu, 10/25/18 - 09:33 am
FDA Approves First New Flu Drug in Nearly 20 Years
  • Xofluxa is a single-dose one-time treatment compared to Tamiflu's twice daily for five day regimen
  • In two trials, patients taking Xofluxa had a shorter duration of flu symptoms... read more
Wed, 10/24/18 - 12:39 pm
Sponsored: Pharma Supply Chain and Quality Experts Can Stay on Top of Their Game at Temperature Controlled Logistics Event
The 18th Annual Temperature Controlled Logistics Conference will bring together supply chain, logistics and quality experts from around the globe to experience four days of ‘unmissable’... read more
Wed, 10/24/18 - 12:30 pm
BeiGene Announces Acceptance of its NDA in China for Zanubrutinib in Certain Types of Leukemia and Lymphoma
  • Zanubrutinib demonstrated a high overall response rate of 80 percent
  • Zanubrutinib was recently granted Fast Track Designation by the US FDA for Waldenström macroglobulinemia (WM)... read more
Wed, 10/24/18 - 11:53 am
Stelara Shines in Three Year Crohn's Disease Study
  • 60.3% of all randomised ustekinumab-treated patients who entered the long-term extension study were in clinical remission at week 152
  • Of those patients who were naïve to TNF... read more
Wed, 10/24/18 - 09:45 am

Pages